Jamie Kang

[ACS Biomaterials Science & Engineering] Scientists utilized 3D printing and inverse molding techniques to form 3D spongy scaffold systems that resemble the intestinal crypt-villus microarchitecture.

[Medical Oncology] The authors tested the potency of morin to inhibit cancer stem cells. They found that morin has significantly reduced colon cancer cell proliferation, colony formation, migration, and colonospheroid formation in a dose-dependent manner.

[Molecular and Cellular Biochemistry] Researchers studied the FEZF1-AS1/miR-92b-3p/ZIC5 axis. They detected the expression of FEZF1-AS1, miR-92b-3p, and ZIC5 via quantitative reverse transcription-PCR, transfected colon cancer cell RKO with lentivirus and conducted FEZF1-AS1 knockdown, and performed cancer-related functional assays.

[Signal Transduction and Targeted Therapy] The authors review the regulatory roles of signaling pathways in gastric cancer potential biomarkers, and therapeutic targets with an emphasis on recent discoveries.

[Oncogene] Investigators present an overview of the current evidence supporting the role of neurotransmitters in colorectal cancer biology and treatment.

[United Therapeutics Corporation] United Therapeutics Corporation announced that the first patient has enrolled in the Phase III TETON2 study which will evaluate Tyvaso in 396 adult patients with idiopathic pulmonary fibrosis at sites outside the United States and Canada.